The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 19.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 24%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $24.
XP Inc.
XP · Nasdaq · USD · Market cap $10.1B
XP Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 17:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
XP Inc. holds its Markup at $19.97. Elevated stress, defensive posture warranted, held for 5 days.
| Phase | Markup |
| Quantitative state | Elevated stress, defensive posture warranted, held for 5 days |
| Price at the screen | $19.97 |
| Valuation | 10.09 trailing · 8.34 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.10 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: financial services
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: financial services | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 31.9% margin of safety to the base estimate.
Third-party analyst targets: 11 covering, consensus Buy. The average target sits +18% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsBrazilian Brokerage Hits Ethical Wall Despite Cheap Looks
Picture a young professional in Sao Paulo opening an app to buy shares or a fund for the first time. XP built the platform that makes those trades simple and cheap across Brazil. Revenue is growing at 10 percent, margins sit near 29 percent and return on equity reaches 23 percent, all at a forward multiple of just 7.1 times. On paper the numbers look attractive next to a fair value well above the current price.
We pass regardless. The business sits squarely inside financial services, which triggers an automatic fail on our ethical screen. No amount of margin of safety or analyst buy ratings changes that rule. We apply the screen precisely so we do not have to debate individual cases after the fact.
The low multiple also carries the usual warning for financial platforms. Revenue can slow quickly when Brazilian rates or markets turn, and currency swings add another layer of volatility that is hard to forecast. Analysis, not advice.
| Forward P/E | 8.3xfairly priced for its growth rate |
| Trailing P/E | 10.1xreasonably valued |
| EPS, trailing | 1.98 |
| EPS, forward | 2.39 |
| Revenue growth | +10.6%steady growth |
| Profit margin | 28.5%healthy profit margins |
| Return on equity | 22.6%an exceptional return on shareholder capital |
| Dividend yield | 125.00% |
| Debt to equity | 6.42heavy leverage: higher risk if revenue softens |
| Current ratio | 1.49adequate liquidity, worth monitoring |
| Beta | 1.10moves a little more than the market |
| Short interest, float | 0.05% |
| 52-week range | 14.80 - 23.13 |
| Market cap | $10.1B |
The risks · The things to watch: its business and earnings are exposed to Cayman Islands and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeXP trades on Nasdaq (the company is based in Cayman Islands). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 4.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 24%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $24.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 24%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $24.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | Dos Santos Bruno Constantino Alexandre | Dir | S - Sale | 123,257 | $2,413,865 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-17 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-08-17 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-08-17 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-08-12 | Maria Elvira Salazar | Republican | buy | 1K–15K |
| 2026-08-12 | Maria Elvira Salazar | Republican | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $18.67 | -20.0% | · | $800 | -20.0% |
| 2 months | $19.99 | -25.3% | · | $747 | -25.3% |
| 3 months | $18.06 | -17.3% | · | $827 | -17.3% |
| 6 months | $17.75 | -15.9% | · | $842 | -15.9% |
| 1 year | $19.76 | -24.4% | $0.18 | $765 | -23.5% |
| 2 years | $17.56 | -14.9% | $0.83 | $898 | -10.2% |
| 3 years | $18.32 | -18.4% | $2.14 | $932 | -6.8% |
| 5 years | $39.38 | -62.1% | $2.14 | $434 | -56.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever XP does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.